Can the influenza (flu) vaccine be administered intramuscularly (IM) to children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intramuscular Influenza Vaccination in Children

Yes, the influenza vaccine can and should be administered intramuscularly to children aged 6 months and older, with specific anatomical sites based on age: the deltoid muscle for older children and the anterolateral thigh for infants and young children. 1

Route of Administration

  • Inactivated influenza vaccines (IIV) are administered intramuscularly using needle and syringe for all pediatric age groups. 1
  • The only exception to needle-and-syringe administration is Afluria Quadrivalent, which may be given via jet injector, but this is approved only for adults aged 18-64 years—not for children. 1

Anatomical Site Selection by Age

For infants and young children:

  • The anterolateral aspect of the thigh is the preferred injection site for infants and young children due to insufficient deltoid muscle mass in this age group. 1, 2, 3

For older children:

  • The deltoid muscle is the preferred site for older children (generally those with adequate muscle mass). 1, 2, 3

Injection Technique

  • Vaccines should be administered at a 90-degree angle to ensure proper intramuscular placement. 2, 4
  • Appropriate needle length must be selected based on patient size and injection site per ACIP General Best Practice Guidelines. 1, 2
  • Aspiration is not required before injection because no large blood vessels exist at the recommended injection sites. 2

Dose Volumes for Children

Children aged 6-35 months:

  • Dose volume varies by product: either 0.25 mL or 0.5 mL depending on the specific vaccine formulation. 1, 3
  • Afluria Quadrivalent: 0.25 mL per dose 1
  • Fluzone Quadrivalent: either 0.25 mL or 0.5 mL per dose (no preference) 1
  • Fluarix, Flucelvax, and FluLaval Quadrivalent: 0.5 mL per dose 1

Children aged 36 months through 17 years:

  • Standard dose is 0.5 mL per dose for all intramuscular IIV products. 1, 3

Critical Pitfalls to Avoid

  • Do not administer influenza vaccine in the buttocks due to potential reduced immunogenicity and risk of sciatic nerve injury. 4
  • If a smaller dose (e.g., 0.25 mL) is inadvertently given to a child requiring 0.5 mL, administer the remaining volume during the same visit or give a full 0.5 mL dose as soon as the patient returns. 1, 2
  • Care must be taken to administer the age-appropriate vaccine at the correct dose volume for each product, as different formulations have different approved volumes for young children. 1

Contraindications

  • History of severe allergic reaction to any vaccine component or previous dose of any influenza vaccine is an absolute contraindication. 1, 3
  • Moderate or severe acute illness with or without fever is a precaution (but minor illnesses without fever do not contraindicate vaccination). 1, 3
  • History of Guillain-Barré syndrome within 6 weeks of previous influenza vaccination is a precaution. 1, 3

Special Considerations for Egg Allergy

  • Children with egg allergy may receive any licensed, age-appropriate influenza vaccine. 1, 2
  • Those with severe egg reactions (angioedema, respiratory distress, recurrent emesis, or requiring epinephrine) should be vaccinated in a medical setting supervised by a provider able to manage severe allergic reactions. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Influenza Vaccination Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Influenza Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Influenza Vaccine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.